Can we reduce both the ‘patient burden’, as well as the ‘healthcare burden’, by ‘decentralizing’ clinical trials?
TORONTO (PRWEB) May 07, 2020
There has been a significant shift in the industry operating model towards hybrid ‘digital’ or ‘virtual’ clinical trials. A diverse spectrum of approaches is being used to accelerate patient recruitment and retention, by ‘localizing’ the trial – bringing it closer to the patient’s home. Can we reduce both the ‘patient burden’, as well as the ‘healthcare burden’, by ‘decentralizing’ clinical trials?
Despite the pharmaceutical industry being highly regulated and a slow adopter of technology, diverse approaches are being used, such as the use of e-consenting tools, social media, a ‘chip in a pill’, wearables and sensors, IOT and a world of ‘connected devices’, telehealth platforms and “virtual exam rooms” and the analysis of sound-bites to diagnose neurological disorders are being used, just to name a few. AI is being utilized to identify mutations in DNA, diagnose genetic disorders and support the development of a ‘precision medicine’ approach. Electronic health records (EHRs) are being mined to identify patients, especially for conditions such as rare diseases. RWD, such as EHRs, claims data, registries, etc. are being analyzed and ‘synthetic control arms’ are being generated to drive go or no-go development decisions. Even clinical trial monitoring is now being centralized, with a focus on predicting risk and integrating quality at the grass-root level.
The healthcare industry continues to struggle with fundamental challenges, in terms of data interoperability, data privacy and data security. Even more fundamental questions that arise include filtering through the data deluge and identifying the right data to be captured and recognizing those key risk indicators that can compromise both the clinical trial and the patient’s life. While the healthcare world is being fueled by data, technology and analytics, we take pride, as an industry, in the fact that we are driving ‘patient-centric’ clinical trials and firmly believe that the newer approaches are more representative of a patient’s real-life experience.
For more information or to register for this event, visit ‘Localizing’ Remote Digital Clinical Trials: Ensuring the ‘Patient Connect’.
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.